Will the biotech need to find a suitor after the halting of a once-promising development program?
In a shaky economy, cash is a valuable measure of a company's worth.
The heart pill could be a blockbuster product.
Since emerging from bankruptcy in 2010, MGM has returned to profitability.
With a foolish Facebook update, CEO Reed Hastings repeats history and raises expectations too high.
Stocks of both companies doubled this year on hope their drugs will be approved for sale in the US.
Vivus becomes the second pharma this year approved to sell a weight-loss treatment.
VIDEO ON MSN MONEY
Copyright © 2013 Microsoft. All rights reserved.
Fundamental company data and historical chart data provided by Morningstar Inc. Real-time index quotes and delayed quotes supplied by Morningstar Inc. Quotes delayed by up to 15 minutes, except where indicated otherwise. Fund summary, fund performance and dividend data provided by Morningstar Inc. Analyst recommendations provided by Zacks Investment Research. StockScouter data provided by Verus Analytics. IPO data provided by Hoover's Inc. Index membership data provided by Morningstar Inc.
The Market Dispatches column has been discontinued. Here's where to find the latest stock and business news on MSN Money, and the latest from market writer Charley Blaine.
MONEY & POLITICS
Breaking up big banks is an untested solution to the too big to fail problem that attempts to isolate and dismantle large, troubled institutions while protecting the rest of the economy.
Which store penalizes you for too many returns? And which one will let you retroactively apply coupons?
The IRS is struggling to combat identify thieves who file fraudulent tax returns in the names of older residents who don't need to file.